Key | % Net Assets |
---|---|
![]() |
5.0% |
![]() |
4.0% |
![]() |
3.7% |
![]() |
3.5% |
![]() |
83.8% |
Name | % Net Assets |
---|---|
GlaxoSmithKline | 5.0% |
BP | 4.0% |
Vodafone Group | 3.7% |
HSBC Holdings | 3.5% |
Lloyds Banking Group | 3.2% |
AstraZeneca | 3.2% |
Legal & General Group | 3.1% |
Reed Elsevier | 3.1% |
Unilever | 2.7% |
Schroder Recovery Fund | 2.5% |
Key | % Net Assets |
---|---|
![]() | 26.40% |
![]() | 15.40% |
![]() | 13.20% |
![]() | 11.50% |
![]() | 8.90% |
Date | 02-Mar-2022 |
---|---|
NAV | 2,294.00p |
Currency | GBP |
Change | -43.00p |
% | -1.84% |
YTD change | 2,294.00p |
YTD % | n/a |
Fund Inception | 30/04/1987 |
---|---|
Fund Manager | Alex Breese |
TER | 1.67 (20-Jun-2012) |
Minimum Investment | |
---|---|
Initial | £1000 |
Additional | n/a |
Savings | £50 |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.09 |
You are here: research